Frederike J. Bemelman

University of Amsterdam - Renal Transplant Unit

Amsterdam

Netherlands

SCHOLARLY PAPERS

3

DOWNLOADS

95

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Antibody and T-Cell Responses 6 Months after Covid-19 mRNA-1273 Vaccination in Patients with Chronic Kidney Disease, on Dialysis, or Living with a Kidney Transplant

Number of pages: 32 Posted: 30 Mar 2022
University of Groningen - Division of Nephrology, University of Groningen - Division of Nephrology, Erasmus University Rotterdam (EUR) - Department of Viroscience, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, University of Groningen - Department of Medical Microbiology and Infection Prevention, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), Donders Institute for Brain Cognition and Behaviour - Radboudumc, Erasmus University Rotterdam (EUR) - Department of Viroscience, Erasmus University Rotterdam (EUR) - Department of Viroscience, Erasmus Medical Center - Viroscience Department, National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, Erasmus University Rotterdam (EUR) - Department of Viroscience, Donders Institute for Brain Cognition and Behaviour - Radboudumc, University of Amsterdam - Department of Experimental Immunology, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, University of Groningen - Division of Nephrology, University of Amsterdam - Renal Transplant Unit, Donders Institute for Brain Cognition and Behaviour - Radboudumc, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation and Independent
Downloads 51 (529,154)

Abstract:

Loading...

COVID-19, mRNA-1273, vaccine, chronic kidney disease, kidney transplantation, dialysis, immunogenicity

2.

SARS-CoV-2 Delta Breakthrough Infections in Vaccinated Patients with Immune-Mediated Inflammatory Diseases Using Immunosuppressants – Data from Two Controlled Prospective Cohort Studies

Number of pages: 26 Posted: 16 Mar 2022
University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, Amsterdam UMC - Department of Neurology and Neurophysiology, Sanquin Research - Department of Immunopathology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, affiliation not provided to SSRN, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Department of Neurology, University of Amsterdam - Department of Neurology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Amsterdam - Renal Transplant Unit, VU University Medical Center - Amsterdam Rheumatology and Immunology Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Groningen - University Medical Center Groningen (UMCG), University of Groningen - Department of Rheumatology and Clinical Immunology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Leiden University - Department of Rheumatology, affiliation not provided to SSRN, Leiden University - Department of Rheumatology, Leiden University - Department of Nephrology, Maastricht University - Division of Nephrology and Clinical Immunology, Department of Immunology, Maastricht UMC+, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Utrecht University - Brain Center Rudolf Magnus, affiliation not provided to SSRN, AmsterdamUMC, University of Amsterdam - Department of Medical Microbiology and Infection Control, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, affiliation not provided to SSRN, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research, affiliation not provided to SSRN, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Pediatric Immunology, Rheumatology and Infectious Disease, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre and Amsterdam UMC - Department of Neurology and Neurophysiology
Downloads 34 (616,379)

Abstract:

Loading...

Breakthrough infectionsCOVID-19SARS-CoV-2Immune mediated inflammatory diseasesAnti-CD20 therapyImmunosuppressantsEpidemiologyIncidenceDisease severityHumoral immunity

3.

Alternative Strategies to Increase the Immunogenicity of Covid-19 Vaccines in Kidney Transplant Recipients Not Responding to Two or Three Doses of an mRNA Vaccine. A Randomized Clinical Trial

Number of pages: 31 Posted: 29 Jul 2022
Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, University of Groningen - Division of Nephrology, University of Amsterdam - Renal Transplant Unit, University of Groningen - Division of Nephrology, Radboud University Nijmegen - Department of Nephrology, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, Erasmus University Rotterdam (EUR) - Department of Viroscience, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, Donders Institute for Brain Cognition and Behaviour - Radboudumc, Donders Institute for Brain Cognition and Behaviour - Radboudumc, University of Amsterdam - Department of Experimental Immunology, University of Groningen - Department of Medical Microbiology and Infection Prevention, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, University of Groningen - Division of Nephrology, University of Amsterdam - Renal Transplant Unit, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, University of Groningen - Division of Nephrology, Donders Institute for Brain Cognition and Behaviour - Radboudumc and Independent
Downloads 10 (807,045)

Abstract:

Loading...

COVID-19, mRNA-1273, Ad26.COV2-S, Vaccine, kidney transplantation, immunogenicity